Thomas Sciascia
Net worth: 3 M $ as of 30/05/2026
Net worth: 3 M $ as of 30/05/2026
Thomas R.
Sciascia is the founder of Trevi Therapeutics, Inc., founded in 2011, serving as Chief Scientific Officer since 2022.
Former jobs include Medical Director at Quintiles, Inc. (California) from 1997 to 2000, Medical Director at Transkaryotic Therapies, Inc. from 2000 to 2001, Chief Medical Officer & Senior Vice President at Penwest Pharmaceuticals Co. from 2001 to 2010, and Faculty Member at Boston University from 1983 to 1997.
Education includes a doctorate from The Trustees of Columbia University in The City of New York in 1979 and an undergraduate degree from Massachusetts Institute of Technology in 1975.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/02/2026 | 221,373 ( 0.18% ) | 3 M $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Founder | 31/12/2010 |
| Companies | Position | End |
|---|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Chief Tech/Sci/R&D Officer | 31/12/2000 |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Chief Tech/Sci/R&D Officer | 31/12/1999 |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/1996 |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions